The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells

被引:75
作者
Kronenwett, R [1 ]
Martin, S [1 ]
Haas, R [1 ]
机构
[1] Univ Dusseldorf, Klin Hamatol Onkol & Klin Immunol, D-40225 Dusseldorf, Germany
关键词
mobilization; CD34(+) cells; transplantation; G-CSF; adhesion molecules; VLA-4; antisense oligonucleotides; integrin antagonists;
D O I
10.1634/stemcells.18-5-320
中图分类号
Q813 [细胞工程];
学科分类号
摘要
CD34(+) hematopoietic stem cells from peripheral blood are commonly used for autologous or allogeneic transplantation following high-dose therapy in malignant diseases. The introduction of hematopoietic growth factors such as G-CSF has greatly facilitated the mobilization of CD34(+) cells. The mechanism of stem cell mobilization is not yet clear. It seems to be a multistep process with a crosstalk between cytokines and adhesion molecules. In this review, the role of hematopoietic growth factors, chemokines, and adhesion molecules for mobilization and homing of CD34(+) cells is summarized, In addition, factors influencing the cytokine-induced mobilization in patients and healthy donors are described, The review closes with an overview of new classes of mobilizing drugs such as monoclonal antibodies, specific peptides, or antisense oligonucleotides targeting adhesion molecules.
引用
收藏
页码:320 / 330
页数:11
相关论文
共 110 条
  • [21] HAAS R, 1994, BLOOD, V83, P3787
  • [22] BLOOD-DERIVED AUTOGRAFTS COLLECTED DURING GRANULOCYTE-COLONY-STIMULATING FACTOR-ENHANCED RECOVERY ARE ENRICHED WITH EARLY THY-1(+) HEMATOPOIETIC PROGENITOR CELLS
    HAAS, R
    MOHLE, R
    PFORSICH, M
    FRUEHAUF, S
    WITT, B
    GOLDSCHMIDT, H
    HUNSTEIN, W
    [J]. BLOOD, 1995, 85 (07) : 1936 - 1943
  • [23] HAAS R, 1992, BONE MARROW TRANSPL, V9, P459
  • [24] HAAS R, 1993, BONE MARROW TRANSPL, V12, P643
  • [25] HAAS R, 1993, EXP HEMATOL, V21, P109
  • [26] SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN LOW-GRADE NON-HODGKINS-LYMPHOMA
    HAAS, R
    MOOS, M
    KARCHER, A
    MOHLE, R
    WITT, B
    GOLDSCHMIDT, H
    FRUHAUF, S
    FLENTJE, M
    WANNENMACHER, M
    HUNSTEIN, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) : 1685 - 1692
  • [27] Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer
    Haas, R
    Schmid, H
    Hahn, U
    Hohaus, S
    Goldschmidt, H
    Murea, S
    Kaufmann, M
    Wannenmacher, M
    Wallwiener, D
    Bastert, G
    Hunstein, W
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (03) : 372 - 378
  • [28] HAAS R, 1990, EXP HEMATOL, V18, P94
  • [29] A critical role of VLA-4 in erythropoiesis in vivo
    Hamamura, K
    Matsuda, H
    Takeuchi, Y
    Habu, S
    Yagita, H
    Okumura, K
    [J]. BLOOD, 1996, 87 (06) : 2513 - 2517
  • [30] Anti-inflammatory activity of c(ILDV-NH(CH2)5CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesion
    Haworth, D
    Rees, A
    Alcock, PJ
    Wood, LJ
    Dutta, AS
    Gormley, JJ
    Jones, HB
    Jamieson, A
    Reilly, CF
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (08) : 1751 - 1760